yellow fever vaccine
/ iBio, Fraunhofer Institute for Molecular Biology and Applied Ecology, Oswaldo Cruz Foundation
- LARVOL DELTA
Home
Next
Prev
1 to 25
Of
71
Go to page
1
2
3
August 26, 2026
Editorial: Emerging arboviruses in the Americas: epidemiology, public health impact, and future preparedness.
(PubMed, Front Public Health)
- No abstract available
Journal • Chikungunya • Dengue Fever • Infectious Disease
August 26, 2026
An index-based system for early alerts of potential zoonotic disease outbreaks.
(PubMed, PLoS One)
- "To validate the model, we used historical Yellow Fever case data from Brazil's Ministry of Health. By supporting surveillance teams in prioritizing prevention and investigation actions, the system enhances the capacity of public health authorities to respond effectively through supporting risk assessment, optimizing resource allocation, and promoting cost-effective strategies for outbreak control."
Journal
June 13, 2026
Effects of hydro-meteorological and geological disasters on vaccine-preventable disease outbreaks and routine immunisation amongst children: A scoping review.
(PubMed, PLOS Glob Public Health)
- "The vaccination studies reported reduction in routine immunisation rates in the months following a disaster, considering infrastructural damage to health facilities and vaccine storage issues as common causes. Finally, there was significant knowledge gap on the effects of specific disasters (e.g., wildfires and volcanic eruptions) and diseases (e.g., influenza, yellow fever, malaria, and dengue).In conclusion, our review reinforce the need for better policies to ensure vaccine equity, resilient health system and safe WASH to prevent vaccine-preventable disease (VPD) outbreaks following hydro-meteorological and geological disasters."
Journal • Dengue Fever • Infectious Disease • Influenza • Malaria • Respiratory Diseases
April 30, 2026
Identification of multiple arbovirus infections/exposure in Northeastern Brazil using a multiplex microsphere immunoassay.
(PubMed, J Clin Microbiol)
- "Several mosquito-borne arboviruses, including dengue (DENV), Zika (ZIKV), West Nile (WNV), yellow fever (YFV), and chikungunya (CHIKV) viruses, have caused disease outbreaks of public health concern in the tropics and subtropics...We reported high sensitivity of nonstructural protein 1 (NS1)-based IgG MIA (94.4%-100% except YFV NS1) and overall low specificity of ZIKV and WNV NS1 due to cross-reactivities from repeated orthoflavivirus infections, including secondary DENV and DENV + ZIKV infections. Using our algorithm and confirmatory tests, we reported multiple arbovirus infections or exposure (DENV + ZIKV, DENV + YFV, DENV + ZIKV + YFV, and/or CHIKV) in the majority of participants from a town in Northeastern Brazil."
Journal • Chikungunya • Dengue Fever • Infectious Disease
December 16, 2025
Reemergence of yellow fever virus in forest and periurban settings in Brazil.
(PubMed, Commun Med (Lond))
- "These findings demonstrate ongoing yellow fever virus activity in Brazil, with forest regions serving as reservoirs for reemergence and periurban areas supporting continued spread. Strengthened genomic and epizootic surveillance is required to detect viral expansion early and inform targeted prevention strategies across Brazil and the Americas."
Journal
October 29, 2025
In Vivo Characterization and Tissue Tropism of a Wild-Type Yellow Fever Virus Isolate from the 2017-2018 Brazilian Outbreak in C57BL/6 IFNAR1-/- Mice.
(PubMed, Viruses)
- "No statistically significant differences were observed between males and females in survival, clinical signs, or viral loads. Altogether, this study provides a robust and reproducible murine model for wild-type YFV infection, offering a valuable platform for investigating viral pathogenesis, host responses, and potential therapeutic interventions."
Journal • Preclinical • Infectious Disease • IFNAR1
October 10, 2025
Identification of multiple arbovirus infections or exposure in Brazil using a multiplex microsphere immunoassay
(ASTMH 2025)
- "In the past few decades, several mosquito-borne arboviruses including dengue (DENV), Zika (ZIKV), West Nile (WNV), yellow fever (YFV), chikungunya (CHIKV), and Mayaro (MAYV) viruses have caused disease outbreaks of public health concern...The results were further compared with a commercial ELISA kit for DENV, ZIKV and CHIKV. In summary, the multiplex and high-throughput MIA assay combined with other confirmations tests can be applied to serodiagnosis and serosurveillance of DENV, ZIKV, WNV, CHIKV and YFV infections/exposure in countries where multiple arboviruses co-circulate."
Chikungunya • Dengue Fever • Infectious Disease
August 14, 2025
Direct Detection of Orthoflavivirus via Gold Nanorod Plasmon Resonance.
(PubMed, Sensors (Basel))
- "Dengue, Zika, yellow fever, chikungunya, and Mayaro arboviruses represent an increasing threat to public health because of the serious infections they cause annually in many countries...Additionally, the functionalized GNRs presented here are promising for supporting virological surveillance studies in mosquitoes. Our findings highlight a fast and highly sensitive method for detecting Orthoflavivirus in both human and mosquito samples, with a detection limit as low as 100 PFU/mL."
Journal • Chikungunya • Dengue Fever • Infectious Disease
July 07, 2025
The global burden of climate-sensitive diseases in Brazil: the national and subnational estimates and analysis, 1990-2017.
(PubMed, Popul Health Metr)
- "The burden of CSDs in Brazil has increased since 1990 considering non-communicable and communicable diseases. The potential impact of climate change on such diseases must be evaluated considering disease dynamics and spatial specificities, such as land cover and climate patterns. The main challenges in Brazil related to CSDs are the investments needed for research regarding the increase in the burden of CSDs, for vector control and social health determinants mitigation."
Journal • Cardiovascular • Dengue Fever • Infectious Disease • Malaria • Respiratory Diseases
July 01, 2025
Colombian consensus on the care of critically ill patients with suspected or confirmed severe yellow fever.
(PubMed, Lancet Reg Health Am)
- "In more severe cases, plasma exchange and renal replacement therapies are recommended. Based on evidence and the GRADE methodology, implementing these strategies aims to improve survival and reduce morbidity in critically ill yellow fever patients."
Journal • Review • Critical care • Hematological Disorders • Hepatology • Hypotension • Infectious Disease • Liver Failure • Renal Disease
April 18, 2025
Quantification of Yellow Fever Virus by Plaque Assay and Focus Formation Assay.
(PubMed, Methods Mol Biol)
- "Cell-based viral quantification assays are useful for viral diagnosis and in the different stages of vaccines development. This chapter will describe in detail a protocol to determine the potency of yellow fever virus in laboratory."
Journal
April 18, 2025
Flow Cytometry as Immunoassay Tool for Research on Yellow Fever Virus.
(PubMed, Methods Mol Biol)
- "Even with the availability of effective vaccines, gaps about understanding the immune pathophysiology and clinical management are still considered a huge challenge for the scientific community. Therefore, such tool has the potential to aggregate in flavivirus setting, being effective in tracking infection in different biological culture systems, animal and human models, as well as in searching for new antiviral drugs and vaccine efficacy."
Journal • Infectious Disease • Inflammation
April 18, 2025
Clinical Features of Human Infection by Yellow Fever.
(PubMed, Methods Mol Biol)
- "Yellow fever (YF) is an arbovirus caused by a flavivirus. However, recently, studies have emerged showing the possibility of YF treatment with Sofosbuvir and plasmapheresis. The use of acetylsalicylic acid, paracetamol, and anti-inflammatory drugs should be avoided."
Journal • Review • Hepatology • Infectious Disease • Liver Failure • Renal Disease
April 18, 2025
A Fast One-Step RT-qPCR to Quantify Yellow Fever Virus.
(PubMed, Methods Mol Biol)
- "Genome copies were quantified by plasmid standard curve designed to NS5 region. This method provides a specific, rapid, and sensitive diagnosis to yellow fever virus (YFV)."
Journal
April 18, 2025
Immunoenzyme Test for Capture of IgM Anti-YFV Class Antibodies: MAC-ELISA.
(PubMed, Methods Mol Biol)
- "IgM anti-yellow fever antibodies are captured by anti-IgM present on the polystyrene surface of the wells of the assay plate.The steps of the technique consist of stages (serum, antigen and anti-flavivirus conjugate - 6B6C-1), with incubation intervals at 37°C and washing. When adding the substrate in the next step, positive reactions (those containing the antigen-antibody complex) are blue in color by the action of the TMB substrate on the peroxidase enzyme. Completion of the reaction by adding the stop solution will cause the positive reaction of blue color to turn yellow."
Journal
April 18, 2025
Enhancing Biosafety Protocols in Laboratories Conducting Research on the Yellow Fever Virus.
(PubMed, Methods Mol Biol)
- "YFV is classified as a Risk Group 3 pathogen by the WHO, necessitating handling in Biosafety Level 3 (BSL3) laboratories. Personnel must be vaccinated against YFV at least 10 days prior to contact, as there have been cases of occupationally acquired infections among healthcare and laboratory workers."
Journal • Infectious Disease
April 18, 2025
Neutralization Tests for Quantification of Specific Antibodies Against Yellow Fever Virus.
(PubMed, Methods Mol Biol)
- "The micro-PRNT version (in 96-well plates) is more operational and has a higher sample throughput than the classic PRNT run in 6-well plates. Here we described both methods to quantify yellow fever neutralizing antibodies."
Journal • Infectious Disease
April 18, 2025
Micro-Focus Reduction Neutralization Tests (mFRNT) for Neutralizing Antibody (Nab) Quantification Against Yellow Fever Virus.
(PubMed, Methods Mol Biol)
- "Although the plaque reduction neutralization test (PRNT) is considered the reference for measuring neutralizing antibodies for Yellow fever virus (YFV), the micro-focus reduction neutralization test (mFRNT) presents many advantages including a higher throughput, a reduced incubation time, and allows the automatic foci count. So, here we describe a detailed mFRNT method that provides a faster neutralization test essential for non-clinical and clinical studies and vaccine design."
Journal
April 18, 2025
Yellow Fever Virus Genotyping Tool Using RT-qPCR Followed by Nucleotide Sequencing and Phylogenetic Analysis.
(PubMed, Methods Mol Biol)
- "Here we describe a genotyping tool to distinguish the vaccine from wild-type viruses. Experimental assays confirmed the discrimination between South American I and vaccine viruses, but in silico analyses also show its potential to be used for the differentiation of all yellow fever virus genotypes."
Journal • Infectious Disease
April 18, 2025
Automation on the Plate Analysis from Yellow Fever Serum Neutralization Assays.
(PubMed, Methods Mol Biol)
- "Companies specialized in microscopy, robotics, and information technology developed robust systems able to standardize the image acquisition and analysis for neutralization assays, which could aid the public health response to emerging viral diseases. In this context, these automated systems aim to obtain images and to identify morphological patterns, setting the best ranges for some parameters from structures of interest, such as circularity, size, color intensity, etc. In this session, we describe the use of automated image acquisition and quantification procedures to increase serum neutralization assays throughput and improving their results accuracy."
Journal • Infectious Disease
April 18, 2025
Yellow Fever Virus Bank Production in Stationary Cell Culture.
(PubMed, Methods Mol Biol)
- "This chapter presents a protocol for producing a yellow fever virus (YFV) bank derived from a batch of YFV 17DD vaccine manufactured at Bio-Manguinhos, using stationary culture of Vero CCL-81 cells. Once established, this virus bank can be applied in plaque assays, YFV surveillance studies, diagnostics, and vaccine development."
Journal • Preclinical
April 18, 2025
ELISA for Detection of Total IgG Against YF 17DD.
(PubMed, Methods Mol Biol)
- "The ELISA technique has attracted widespread interest as a sensitive, efficient, safe, and inexpensive way to measure antigen-antibody reactions since its description in 1971 to current days. Here it is described an indirect ELISA protocol to detect anti-YF 17DD antibodies as an important tool to evaluate immunogenicity to yellow fever vaccine candidates."
Journal
April 18, 2025
Immunoenzyme Test for Detection of IgG Anti-YFV Class Antibodies: IgG-ELISA.
(PubMed, Methods Mol Biol)
- "The ELISA-IgG technique is based on the principle of specificity of the immune response with the detection of antibodies of the IgG class, using the formation of an antigen-antibody complex, in serum, plasma, blood, or CSF."
Journal
April 18, 2025
Conventional RT-PCR for Yellow Fever Virus.
(PubMed, Methods Mol Biol)
- "Molecular methods of diagnostics for viral genome detection offer a fast, sensitive, and highly specific alternative to serological assays for early diagnostics during the viremic phase of infection or in fatal cases tissues. This chapter presents some conventional RT-PCR protocols used in molecular diagnostics, among the several available in the literature."
Journal • Infectious Disease
April 18, 2025
Purification of Yellow Fever Virus by Liquid Chromatography.
(PubMed, Methods Mol Biol)
- "In addition to being used for vaccine manufacture, purified viral antigens can have a number of other applications, such as antibody production; substrate and control in immunoenzymatic detection tests (ELISA); and, if they are inactivated, can decrease the level of security for manipulation of the virus to assist in research and development. Here it will be presented an overview of viral purification techniques and the processes developed to purify the yellow fever virus."
Journal
1 to 25
Of
71
Go to page
1
2
3